- Home
- MGIC vs RLAY Comparison
MGIC vs RLAY Comparison
Compare MGIC & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGIC
- RLAY
- Stock Information
- Founded
- MGIC 1983
- RLAY 2015
- Country
- MGIC Israel
- RLAY United States
- Employees
- MGIC N/A
- RLAY N/A
- Industry
- MGIC Computer Software: Prepackaged Software
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MGIC Technology
- RLAY Health Care
- Exchange
- MGIC Nasdaq
- RLAY Nasdaq
- Market Cap
- MGIC 990.3M
- RLAY 803.4M
- IPO Year
- MGIC 1991
- RLAY 2020
- Fundamental
- Price
- MGIC $20.21
- RLAY $6.92
- Analyst Decision
- MGIC Buy
- RLAY Strong Buy
- Analyst Count
- MGIC 2
- RLAY 8
- Target Price
- MGIC $18.00
- RLAY $17.25
- AVG Volume (30 Days)
- MGIC 25.4K
- RLAY 1.7M
- Earning Date
- MGIC 11-17-2025
- RLAY 11-05-2025
- Dividend Yield
- MGIC 3.02%
- RLAY N/A
- EPS Growth
- MGIC 16.93
- RLAY N/A
- EPS
- MGIC 0.78
- RLAY N/A
- Revenue
- MGIC $584,528,000.00
- RLAY $8,355,000.00
- Revenue This Year
- MGIC $11.72
- RLAY $27.33
- Revenue Next Year
- MGIC $6.24
- RLAY $7.40
- P/E Ratio
- MGIC $26.33
- RLAY N/A
- Revenue Growth
- MGIC 11.98
- RLAY N/A
- 52 Week Low
- MGIC $10.42
- RLAY $1.78
- 52 Week High
- MGIC $22.00
- RLAY $7.00
- Technical
- Relative Strength Index (RSI)
- MGIC 48.56
- RLAY 73.89
- Support Level
- MGIC $20.03
- RLAY $6.31
- Resistance Level
- MGIC $21.00
- RLAY $6.79
- Average True Range (ATR)
- MGIC 0.58
- RLAY 0.40
- MACD
- MGIC -0.02
- RLAY 0.05
- Stochastic Oscillator
- MGIC 28.90
- RLAY 95.63
About MGIC Magic Software Enterprises Ltd.
Magic Software Enterprises Ltd is a software development company. The company's operating segment includes Software Services and IT Professional Services. The company generates maximum revenue from the IT Professional Services segment. IT Professional Services segment offers IT services in the areas of infrastructure design and delivery, application development, technology planning and implementation services, communications services and solutions, as well as supplemental outsourcing services. Geographically, it derives a majority of revenue from the United States and also has a presence in Israel, Europe, Japan, and Other countries.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).